Barclays’s Fabrinet FN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-4,000
Closed -$252K 4989
2020
Q3
$252K Hold
4,000
﹤0.01% 3692
2020
Q2
$250K Hold
4,000
﹤0.01% 3889
2020
Q1
$218K Hold
4,000
﹤0.01% 4233
2019
Q4
$259K Buy
+4,000
New +$231K ﹤0.01% 4836
2018
Q4
Sell
-1,000
Closed -$46K 7052
2018
Q3
$46K Buy
+1,000
New +$43K ﹤0.01% 6126
2018
Q1
Sell
-300
Closed -$9K 7142
2017
Q4
$9K Hold
300
﹤0.01% 6532
2017
Q3
$11K Sell
300
-900
-75% -$36.8K ﹤0.01% 6084
2017
Q2
$51K Buy
+1,200
New +$45.2K ﹤0.01% 5353

Other funds holding FN

Barclays's FN Position: Q2 2026 in Review

Barclays increased its Fabrinet (FN) stake by 80% in Q2 2026, buying an estimated $9.3M and bringing the position to 32,552 shares worth $18.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1178.

Barclays first reported a position in FN in Q2 2013 and has held it in 52 quarters since. The position peaked at $36.6M in Q4 2025. 757 funds tracked by Wall St. Rank hold FN as of Q2 2026.

  • Barclays held 32,552 shares of Fabrinet worth $18.3M as of Q2 2026.
  • Barclays bought 14,433 Fabrinet shares in Q2 2026, an estimated $9.3M.
  • Fabrinet made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1178 holding.
  • Barclays first reported a position in Fabrinet in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Fabrinet position peaked at $36.6M in Q4 2025.
  • 757 funds tracked by Wall St. Rank held Fabrinet as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.